Oncology
Article
Hospitalizations for fracture in patients with metastatic disease: primary source lesions in the United States
FDA/CDC
Imfinzi approved for stage III unresectable NSCLC
Conference Coverage
The T-cell repertoire in NSCLC: Therapeutic implications
New findings regarding the T-cell repertoire in NSCLC patients could have implications for the use of TIL therapy, checkpoint blockade, and more...
News
Transparency lacking in oncology clinical pathways
Health plans are under fire for the hidden conflicts of interest in their clinical pathway panels.
Outcomes Research in Review
Brentuximab Vedotin with Chemotherapy Improves Progression-Free Survival in Advanced-Stage Hodgkin’s Lymphoma
Outcomes Research in Review
Addition of Durvalumab After Chemoradiotherapy Improves Progression-Free Survival in Unresectable Stage III Non-Small-Cell Lung Cancer
News
Adolescents with chronic health conditions often undervaccinated
But better flu vaccination suggests it can be done well in high-risk teens.